Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 298.90
-2.65 (-0.88%)
Sep 4, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.32 trillion as of September 4, 2026. Its market cap has decreased by -18.41% in one year.
Market Cap
1.32T
Enterprise Value
1.42T
Revenue
329.43B
Ranking
n/a
PE Ratio
11.41
Stock Price
298.90
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.32T, an increase of 2,773.76%. That is a compound annual growth rate of 12.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.32T | -8.53% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 129.25B |
| Coloplast | 102.38B |
| Demant | 61.54B |
| ALK-Abelló | 46.33B |
| H. Lundbeck | 43.68B |
| Zealand Pharma | 20.80B |
| Ambu A/S | 17.95B |
| Bavarian Nordic | 16.32B |